Angela Talley
Chief Tech/Sci/R&D Officer chez SPERO THERAPEUTICS, INC.
Profil
Angela Talley is currently working as the Senior Vice President of Clinical Development at Spero Therapeutics, Inc. She previously worked as the Executive Director of Clinical Development at Allergan Ltd.
Dr. Talley holds a doctorate degree from the Icahn School of Medicine at Mount Sinai.
Postes actifs de Angela Talley
| Sociétés | Poste | Début |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Angela Talley
| Sociétés | Poste | Fin |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | - |
Formation de Angela Talley
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
